Related Experiment Video
Updated: May 19, 2026
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clostridium difficile: an emerging pathogen in children
Natalia Khalaf1, Jonathan D Crews, Herbert L DuPont
1Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Insights
Clostridium difficile infection (CDI) is increasingly recognized in children, especially those aged 1-5. Understanding pediatric CDI pathogenesis and risk factors is crucial for developing effective treatments and prevention strategies.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Clostridium difficile is an emerging enteric pathogen in children, with historically low recognition of clinical infection.
- While infants often carry C. difficile asymptomatically, recent data show increasing Clostridium difficile infection (CDI) prevalence in pediatric populations.
- Pediatric CDI pathogenesis and factors influencing toxin-mediated effects in infants are not well understood.
Purpose of the Study:
- To highlight the growing importance of Clostridium difficile infection (CDI) in children.
- To underscore the need for further research into pediatric CDI pathogenesis.
- To emphasize the necessity of developing targeted therapeutic and preventative strategies for pediatric CDI.
Main Methods:
- Review of epidemiological surveillance data on pediatric Clostridium difficile infection (CDI).
- Analysis of existing literature on C. difficile colonization and infection in pediatric populations.
- Comparison of pediatric and adult risk factors for Clostridium difficile infection (CDI).
Main Results:
- Clostridium difficile infection (CDI) prevalence is rising in children, particularly those aged 1-5 years.
- Traditional adult risk factors like antibiotic use may be less relevant for community-acquired pediatric CDI.
- Asymptomatic colonization is common in infants, but the reasons for reduced toxin effects are unclear.
Conclusions:
- Clostridium difficile infection (CDI) represents a significant and growing concern in pediatric healthcare.
- Further investigation into the unique aspects of pediatric CDI pathogenesis is urgently required.
- Optimal treatment and prevention strategies for Clostridium difficile infection (CDI) in children need to be established.
Abstract:
Clostridium difficile is emerging as an important enteric pathogen in children. Historically considered as an asymptomatic colonizer of the gastrointestinal tract, C. difficile infection (CDI) has not been well-studied in pediatric populations. While asymptomatic carriage remains high among infants, recent epidemiological surveillance has demonstrated a rise in the prevalence of CDI in both healthcare and community settings, particularly in children 1-5 years of age. The pathogenesis of pediatric CDI, including the factors underlying the absence of toxin-mediated effects among colonized infants, remains ill-defined. Studies suggest that traditional adult CDI risk factors such as antibiotic and healthcare exposure may not be as important for children who acquire CDI in the community. As recognition of the significant impact of CDI in children increases, the pressing need for deepening our understanding of this disease and identifying optimal therapeutic and preventative strategies is becoming apparent.
Related Concept Videos
01:18Bacterial Gastroenteritis
01:25Clinical Significance of Antibiotic Resistance
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
01:29Staphylococcal Skin Infections
01:28Diphtheria
01:30Reservoir of Infection